Prognostic factors in squamous cell carcinoma of the head and neck

Onkologie

Volumn 25, Issue 3, 2002, Pages 208-212

  Wendt, Thomas G ^a   Bank, P ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Head and neck neoplasm; Prognostic factor; Squamous cell carcinoma

Indexed keywords

CISPLATIN; FLUOROURACIL; MITOMYCIN C; PROTEIN P53;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CORRELATION FUNCTION; HEAD AND NECK CANCER; HISTOLOGY; HUMAN; HYPOXIA; LYMPH NODE; METASTASIS; PROGNOSIS; REVIEW; SQUAMOUS CELL CARCINOMA; TUMOR NECROSIS; TUMOR VOLUME; ADJUVANT THERAPY; CANCER INVASION; HEAD AND NECK TUMOR; LYMPH NODE METASTASIS; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; SURVIVAL RATE;

CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; HUMAN; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OTORHINOLARYNGOLOGIC NEOPLASMS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE; HUMANS;

EID: 0035996212     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000064313     Document Type: Review

References (54)

1. Krebsatlas der Bundesre-publik Deutschland, ed 3
2. Phase I study of anti-epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer
3. Primary head and neck cancer: Histopathologic predictors of recurrence after neck dissection in patients with lymph node involvement
4. Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma
5. Does node location affect the incidence of distant metastases in head and neck squamous cell carcinoma?
6. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck: Final report of a randomized trial
7. Chemoradiotherapy, as compared to radiotherapy alone, significantly increases disease-free and overall survival in head and neck cancer patients after surgery: Results of EORTC phase III trial 22931
8. The effect of loco-regional control on distant metastatic dissemination in carcinoma of the head and neck: Results of an analysis from the RTOG database
9. Primary radiotherapy of larynx and pharynx carcinoma - An analysis of some factors influencing local control and survival
10. Nodal CT density and total tumor volume as prognostic factors after radiation therapy of stage II/IV head and neck cancer
11. The influence of quantitative tumor volume measurements on local control in advanced head and neck cancer using concomitant boost accelerated superfractionated irradiation
12. Full-dose reirradiation for unresectable head and neck carcinoma: Experience at the Gustave-Roussy Institute in a series of 169 patients
13. A randomized trial of radiation therapy compared to split course radiation therapy combined with mitomycin c and 5-fluorouracil as initial treatment for advanced laryngeal and hypopharyngeal, squamous carcinoma
14. Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy - Results of a multicentric randomized German trial in advanced head-and-neck cancer
15. Simultaneous radio-chemotherapy increases local control and survival in locally advanced head and neck cancer. An analysis of a randomized multicenter study
16. Does histologic grade have a role in the management of head and neck cancers?
17. Carcinoma of the nasopharynx treated by radiotherapy alone: Determinants of distant metastasis and survival
18. Cell proliferation and differentiation in squamous carcinoma
19. Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 Gy in 7 weeks
20. In vivo cell kinetics in elderly patients affected by squamous cell carcinoma of the head and neck
21. p53 mutations as a prognostic marker in advanced laryngeal carcinoma
22. p53, apoptosis and radiosensitivity - Experimental and clinical data
23. Squamous cell carcinoma of the oropharynx: Ki-67 and p53 can identify patients at high risk for local recurrence after surgery and postoperative radiotherapy
24. Intratumoral microvessel density predicts local treatment failure of radically irradiated squamous cell cancer of the oropharynx
25. Role of interstitial brachytherapy in the treatment of malignant disease
26. Conservation therapy in patients with head and neck carcinoma
27. Is a surgical resection leaving positive margins of benefit to the patient with locally advanced squamous cell carcinoma of the head and neck: A comparative study using the Intergroup Study 0034 and the Radiation Therapy Oncology Group head and neck database
28. Prognostic factors of local outcome for T1, T2 carcinomas of oral tongue treated by iridium 192 implantation
29. Radical external beam radiotherapy for 333 squamous carcinomas of the oral cavity - Evaluation of late morbidity and a watch policy for the clinically negative neck
30. Pattern of failure in long-term survivors of radio-chemotherapy of head and neck cancer
31. Chemotherapy added to locoregional treatment for head and neck squamous cell carcinomas: Three metaanalyses of updated individual data
32. Neoadjuvant chemotherapy for organ preservation: Current status
33. Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck
34. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers
35. Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: Results of the Yale Mitomycin Randomized Trials
36. Hyperfractionated radiotherapy with or without concurrent low dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: A prospective randomized trial
37. Treatment of advanced squamous cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy
38. Results of radical radiotherapeutic treatment of carcinoma of the pyriform sinus
39. Analysis of the results of irradiation in the treatment of squamous cell carcinoma of the pharyngeal walls
40. A prospective randomized trial of hyperfractionated versus conventional once daily radiation for advanced squamous cell carcinoma of the larynx and pharynx
41. A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 90003
42. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy
43. Clinical implications of 3D-conformal radiotherapy
44. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer
45. Oropharyngeal cancer in the elderly
46. Radiation therapy in the elderly with head and neck cancer
47. Advanced head and neck cancer: Long-term results of chemoradiotherapy, complications and induction of second malignancies
48. Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinoma
49. Hemoglobin is an independent prognostic factor in locally advanced head & neck cancer - Three-year results from a German multicentre trial (ARO 95/6)
50. Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx
51. Correction of cancer anemia - Impact on disease course, prognosis and treatment efficacy, particularly for patients undergoing radiotherapy
52. Ki-67 and p53 in T2 laryngeal cancer
53. P53 overexpression in head and neck carcinoma and radiotherapy results
54. p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma